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Minimally invasive surgery is being used with increasing frequen-
cy in gynecological oncology. Many reports have shownminimally in-
vasive surgery to compare favorably with laparotomy in regards to
surgical and oncologic outcomes. The Gynecologic Oncology Group
(GOG) recently reported the results of a prospective randomized
trial (LAP-2) comparing exploratory laparotomy to laparoscopy for
the management of endometrial cancer (Walker et al., 2009). They
reported no signiﬁcant differences in intra-operative blood loss,
transfusion rates or intra-operative complications between the two
groups despite a longer duration of surgery in the laparoscopic
group. In addition, there were fewer moderate to severe post-
operative adverse events in the laparoscopic group compared with
the exploratory laparotomy group. Furthermore, the safety and feasi-
bility of performing robotic surgery in women with endometrial can-
cer has been noted. To date, there are limited data available on the
long-term outcomes and risk of disease recurrence in women under-
going minimally invasive surgery for endometrial cancer.⁎ Corresponding author: Department of Gynecologic Oncology, The University of
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A 65-year-old patient presented to her gynecologist with a several
month history of intermittent postmenopausal bleeding. An endome-
trial biopsy was performed showing a grade 2 endometrioid endome-
trial adenocarcinoma. The patient's family history was signiﬁcant
for her father being diagnosed with bladder cancer at age 90
and her maternal grandfather being diagnosed with colon cancer
at age 65. She underwent a robotic hysterectomy and bilateral
salpingo-oophorectomy (BSO) with pelvic washings. No evidence of
extra-uterine disease was noted. Intraoperative frozen section
showed a grade 2 endometrioid adenocarcinoma of the endometrium
with less than 50% myometrial invasion, and lymphadenectomy was
not performed. The surgery was uncomplicated and the patient was
discharged home on postoperative day one. The ﬁnal pathologic ﬁnd-
ings were a grade 2 endometrioid endometrial adenocarcinoma mea-
suring 3.0×3.0×0.8 cm, with 5 of 17 mm of myometrial invasion and
lymphovascular space invasion (LVSI) present. The pelvic washings,
cervix and adnexa showed no evidence of malignancy. The patient
was treated with postoperative vaginal cuff brachytherapy and re-
ceived ﬁve fractions over a 10-day period. A 3.5 cm Delclos dome cyl-
inder was used with the entire length of the dome treated. Therefore,
only 2.5 cm of the vaginal apex was treated and the prescription was
6.0 Gy to the surface of the vaginal dome, giving approximately 3.6 Gy
to 5 mm per fraction.
The patient was followed every 3 months for surveillance without
evidence of disease. Approximately 17 months following her surgery,
she presented with nausea, vomiting and abdominal pain. Abdominal
X-rays revealed a paucity of gas in the large intestine and rectum and
dilated loops of small bowel consistent with early partial small bowel
obstruction. Computed tomography (CT) scan ﬁndings of the abdo-
men and pelvis were consistent with a single site of obstruction in
the terminal ileum (Fig. 1). She underwent exploratory laparotomy
and was noted to have adhesions between loops of small bowel and
the right pelvic sidewall as well as the vaginal cuff. Just above the vag-
inal cuff, there was a contained perforation in the terminal ileum,
measuring 1.2 cm in diameter and located 14 cm from the ileocecal
valve (Fig. 2). The affected segment of small bowel was therefore
transected and a side-to-side anastomosis was performed using a
stapler. A complete survey of the abdomen and pelvis revealed no
other evidence of recurrent disease.
Fig. 1. Computed tomography image of a single site of small bowel obstruction.
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which resolved with conservative management. In addition, she de-
veloped a wound infection and separation treated with vacuum
assisted closure (V.A.C.®, KCI, San Antonio, Texas). She was dis-
charged home on postoperative day 13. The ﬁnal pathologic analysis
showed a well-differentiated adenocarcinoma invading the wall of
the ileum, consistent with patient's prior endometrioid endometrial
adenocarcinoma. Tumor cells were located within the bowel wall,
within the pericolonic fat, serosa, and submucosa. Focal involvement
of the mucosa was noted as well. The remainder of the bowel showed
no evidence of disease. The patient was subsequently treated with
chemotherapy consisting of six cycles of paclitaxel and carboplati-
num. The patient is currently without evidence of disease 22 months
after completing therapy.
Discussion
Minimally invasive surgery offers several advantages for the man-
agement of women with endometrial cancer. Reported beneﬁts in-
clude reduced postoperative morbidity, shorter hospital stay and
less postoperative pain, resulting in more rapid recovery and return
to normal activity (Walker et al., 2009). Despite these advantages,
minimally invasive surgery for the management of endometrial can-
cer has some limitations including increased duration of surgery
and the inability to fully examine the small bowel and mesentery.
In the case presented, the patient developed a small bowel perfo-
ration 17 months following robotic surgery and vaginal cuff brachy-
therapy for presumed early stage endometrial cancer. It remainsFig. 2. Small bowel perforation noted at the time of surgery.unclear if the metastatic implant causing the bowel perforation was
present at the time of initial surgery or represents a single site of re-
current disease. In addition, the contributing effect of vaginal cuff
brachytherapy is uncertain. Vaginal cuff brachytherapy is used to pre-
vent recurrences in the upper third of the vagina by providing direct
radiation to the vaginal cuff with limited spread. It has the advantage
of directing the highest possible homogeneous radiation dose to the
target tissue, while exposing the normal surrounding structures to
minimal radiation (Tuncel et al., 2009). Following hysterectomy, it
may be hypothesized that bowel may be more likely to be exposed
to radiation treatment. The effects of radiation exposure to large
bowel during whole pelvic treatment have been well characterized,
and cases of bowel perforation have been reported (Ramirez et al.,
2001). However, the effects of vaginal cuff brachytherapy on the
bowel are believed to be minimal. At the time of surgical exploration
several adhesions were noted between the small bowel and the right
pelvic sidewall and vaginal cuff, potentially bringing the small bowel
in close proximity to the radiation. However, given that the area of
small bowel perforation contained active disease, it appears unlikely
that the limited radiation doses to the area contributed to the
perforation.
In order to maintain adequate control over the uterus during sur-
gery, we commonly use a manipulator with an inﬂatable intrauterine
balloon (V-Care, ConMed, Utica, NY). Previous studies have proposed
that use of an intrauterine balloon may increase the risk of positive
peritoneal washing cytology in women with endometrial cancer
(Lim et al., 2008). In the current case, the pelvic washings collected
after placement of the uterine manipulator were negative for malig-
nancy. It appears unlikely that the use of the uterine manipulator con-
tributed to the recurrent metastatic disease in this case.
In summary, laparoscopic and robotic surgery offers several ad-
vantages to women with endometrial cancer and other gynecologic
malignancies. Although short-term oncologic outcomes appear simi-
lar to laparotomy, longer follow-up is required to conﬁrm that recur-
rence and long-term survival rates are equivalent. In addition,
minimally invasive surgery is limited by the inability to fully examine
the small intestine and mesentery. It is unclear in this case if the
bowel implant discovered 17 months after the index surgery was
due to metastasis or was simply not observed during the patient's ini-
tial surgery. While patients are undergoing surveillance following
minimally invasive surgery for endometrial cancer, it is important to
consider single site metastasis or recurrence as a cause of bowel
obstruction.
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